Tevogen Bio Holdings Stock Fundamentals
| TVGNW Stock | 0.04 0 12.00% |
Tevogen Bio Holdings fundamentals help investors to digest information that contributes to Tevogen Bio's financial success or failures. It also enables traders to predict the movement of Tevogen Stock. The fundamental analysis module provides a way to measure Tevogen Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tevogen Bio stock.
Tevogen |
Tevogen Bio Holdings Company Net Income Analysis
Tevogen Bio's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Tevogen Bio Net Income | (22.04 M) |
Most of Tevogen Bio's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tevogen Bio Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Tevogen Bio Holdings reported net income of (22.04 Million). This is 106.46% lower than that of the Healthcare sector and 131.47% lower than that of the Biotechnology industry. The net income for all United States stocks is 103.86% higher than that of the company.
Tevogen Bio Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tevogen Bio's current stock value. Our valuation model uses many indicators to compare Tevogen Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tevogen Bio competition to find correlations between indicators driving Tevogen Bio's intrinsic value. More Info.Tevogen Bio Holdings is currently regarded as top stock in net income category among its peers. It also is currently regarded as top stock in cash flow from operations category among its peers . At this time, Tevogen Bio's Net Income is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Tevogen Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Tevogen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tevogen Bio's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tevogen Bio could also be used in its relative valuation, which is a method of valuing Tevogen Bio by comparing valuation metrics of similar companies.Tevogen Bio is currently under evaluation in net income category among its peers.
Tevogen Fundamentals
| Net Income | (22.04 M) | ||||
| Cash Flow From Operations | (8.66 M) | ||||
| Total Asset | 357.14 M | ||||
| Retained Earnings | (14.78 M) | ||||
| Working Capital | (76.1 K) | ||||
| Net Asset | 357.14 M |
About Tevogen Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tevogen Bio Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tevogen Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tevogen Bio Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Tevogen Stock Analysis
When running Tevogen Bio's price analysis, check to measure Tevogen Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tevogen Bio is operating at the current time. Most of Tevogen Bio's value examination focuses on studying past and present price action to predict the probability of Tevogen Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tevogen Bio's price. Additionally, you may evaluate how the addition of Tevogen Bio to your portfolios can decrease your overall portfolio volatility.